
Medical Director & Consultant Urologist
MBBS (Singapore), MRCS (Edin) FRCS-Urol (Glas), FAMS (Urol)

For couples struggling to conceive, infertility is more common in Singapore than many realise. Around one in seven couples experience fertility challenges, with male factors contributing to approximately 50–60% of cases, either alone or in combination with female factors.
Intracytoplasmic sperm injection (ICSI) is a well-established assisted reproduction technique designed to address these challenges. When issues such as low sperm count, reduced motility or abnormal sperm structure interfere with fertilisation, ICSI offers a targeted method of overcoming male-factor infertility and supporting conception.
ICSI is an assisted reproductive technique in which a single sperm is injected directly into the cytoplasm of a mature egg under high-power microscopic guidance. It is performed as a specific step within an IVF cycle and is carried out by trained embryology professionals in a closely controlled laboratory setting.
The key difference between ICSI and conventional IVF lies in how fertilisation occurs. In standard IVF, thousands of sperm are placed together with an egg, allowing fertilisation to take place through natural sperm-egg interaction. In ICSI, a carefully selected sperm is instead injected directly into the egg using specialised micro-instruments.
Outcomes vary between individuals and depend on multiple biological factors.
ICSI may be recommended when a detailed assessment has found that male infertility is causing difficulty in achieving a pregnancy. Whether due to issues involving semen quality, sperm production, sperm function or reproductive anatomy, there exists an underlying problem that compromises the sperm's ability to reach or fertilise an egg. Several root causes of this male infertility are:
ICSI may also be discussed when standard in vitro fertilisation (IVF) has resulted in unsatisfactory fertilisation rates or when sperm parameters are significantly affected. A urologist or fertility specialist must ultimately determine the appropriateness of ICSI based on specific clinical findings and test results unique to each couple.
Common indications of male infertility include:
Before ICSI or any other form of assisted reproductive technology is considered, a fertility clinic needs to conduct a thorough assessment. This process helps identify the underlying causes of infertility and supports informed treatment decisions.
The evaluation typically includes the following components:
ICSI forms part of a standard IVF treatment cycle and follows many of the same steps as a traditional IVF procedure. The key difference lies in how fertilisation is achieved in the laboratory.
The process typically involves the following stages:
Every stage in this process is strictly regulated and performed by skilled professionals in licensed fertility clinics.
As with any assisted reproductive treatment, it is important to consider both the potential benefits and limitations of intracytoplasmic sperm injection when discussing suitability and expectations.
In specific clinical situations, ICSI may offer meaningful advantages:
The technique also has certain limitations that must be considered:

ICSI offers a potential pathway forward for couples facing specific sperm-related challenges. However, depending on the underlying cause of male infertility and the results of a full clinical assessment at a urological health clinic, other treatment approaches may be appropriate.
These may include:
At Urology Practice, we strive to provide high-quality, targeted and compassionate care to help men struggling with fertility. Through a diagnostic evaluation and personalised clinical assessment with our urologist Dr Jonathan Teo, we can determine whether ICSI is an appropriate option. Contact us today to schedule an appointment, so we can guide you towards the most suitable fertility treatment for your individual circumstances.

Qualifications & Credentials:
Dr Jonathan Teo is a fellowship-trained consultant urologist in Singapore with extensive expertise in men’s health, urological cancers, and minimally invasive treatments. He was formerly the Director of Andrology at Singapore General Hospital and an elected EXCO member of the Society of Men’s Health Singapore. Dr Teo specialises in erectile dysfunction, male subfertility, and advanced treatments for benign prostatic hyperplasia (BPH).
More About Dr Teo